A comparison of the plasma levels and safety of coenzyme Q10 from 4 different formulations in healthy adult volunteers.

Medlab Clinical0 个研究点目标入组 8 人开始时间: 2016年11月7日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1) Participants > 18 years of age at time of entry on study
•2) Cognitive ability to understand informed consent process and to give informed consent to the experimental treatment
•3) Participants agree to undergo venipuncture on multiple occasions or have a catheter inserted
•4) Participants agree to adhere to the study protocol
•5) No history of any chronic diseases

•1) Any clinically relevant abnormal findings which, in the opinion of the investigators / clinicians, may put the participant at risk of adverse events because of participation in the clinical trial including: physical examination, clinical chemistry, haematology, urinalysis, vital signs
•2) Any chronic diseases
•3) Alcohol abuse
•4) Pregnant or nursing an infant
•5) Have not been prescribed (medications) or have administered Coenzyme Q10 or any other supplement or vitamin or mineral or herbal medicine in the last week (note: participation will include a 1 week washout period)
•6) Any psychiatric disorders by history or examination that would prevent completion of the study or result in possible adverse events for the participant
•7) The use of illicit drugs

发起方

Medlab Clinical